Company Information
Industry 批发和零售业
Company Introduction 上海第一医药股份有限公司是一家以批发和零售为主营业务的医药流通企业,经过五十年的经营发展,在零售方面,公司拥有大型医药零售旗舰店--"上海第一医药商店",同时还拥有一批著名的专业药店,如"冠心药房",以及百年老字号特色药房,如"五洲大药房"、"老德记药房"等;在专业经营方面,公司旗下具有100多年历史的号称"化剂元老"、"天平大王"的上海长城华美仪器化剂有限公司.在上海市医疗体制改革中,公司下属的医药一店、灵林药房、博山药房等7家药房已被定为上海市医保定点药房,占上海定点药房五分之一。
Main Business 经销化学原料药、化学药制剂、生物制品、中西药、百货等
Legal Representative 张海波
Top Executives
董事长:张海波
副董事长:姚军
董事:陈陟峰,张睿,姚军,周昱,张海波,李劲彪
独立董事:汪丰,唐松莲,程俊佩
Top 5 Shareholder
Shareholder name Nature Holding Date
百联集团有限公司流通A股44.95%31/03/2024
吉林敖东药业集团股份有限公司流通A股4.93%31/03/2024
上海达安房产开发有限公司流通A股0.76%31/03/2024
张淑华流通A股0.73%31/03/2024
上海南上海商业房地产有限公司流通A股0.57%31/03/2024
Company Secretary 孙峥
Solicitors 上海市第一律师事务所
Auditors 大华会计师事务所
Tel No 021-64337282
Fax No 021-64337191
Website www.shdyyy.com.cn
Email shcred@online.sh.cn
Company Address
Register: 上海市黄浦区南京东路616号
Office: 上海市徐汇区小木桥路681号20楼
Listing Date 24/02/1994
Shares Capital
Shares Capital: 223,086,347
Total A Share: 223,086,347
Listed A Share: 223,086,347
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.400
DPS(RMB)* ¥ 0.125
NBV Per Share(RMB)* ¥ 4.489
Market Capitalization(RMB) 2.436B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.